Who Holds Traws Pharma, Inc. (TRAW)? 34 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 34 holders, $5 million in total.
Largest holders
The 34 largest by value. Change in shares against Q1 2026.
New positions
13 managers13 managers opened a position, the largest by value Ally Bridge Group (NY) LLC.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Ally Bridge Group (NY) LLC | 786,236 | $663,033 | New | 13F |
| SPHERA FUNDS MANAGEMENT LTD. | 398,486 | $336,043 | New | 13F |
| Alyeska Investment Group, L.P. | 164,376 | $138,618 | New | 13F |
| Kynam Capital Management, LP | 84,400 | $71,175 | New | 13F |
| NORTHERN TRUST CORP | 37,454 | $31,585 | New | 13F |
| XTX Topco Ltd | 18,092 | $15,257 | New | 13F |
| HUNTINGTON NATIONAL BANK | 4,676 | $3,943 | New | 13F |
| BARCLAYS PLC | 1,947 | $1,642 | New | 13F |
| Federation des caisses Desjardins du Quebec | 500 | $414 | New | 13F |
| HRT FINANCIAL LP | 91,220 | $76 | New | 13F |
Added
9 managers9 managers added shares, the largest by value ORBIMED ADVISORS LLC.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 1,203,260 | $1 million | +99% | 13F |
| ADAR1 Capital Management, LLC | 597,729 | $504,065 | +288% | 13F |
| Lynx1 Capital Management LP | 559,470 | $471,801 | +3611% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 330,049 | $278,231 | +498% | 13F |
| JANE STREET GROUP, LLC | 216,006 | $182,158 | +917% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 111,365 | $93,915 | +44% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 54,511 | $45,953 | +71% | 13F |
| Tower Research Capital LLC (TRC) | 5,142 | $4,336 | +30% | 13F |
| SBI Securities Co., Ltd. | 1,721 | $1,451 | +1245% | 13F |
Cut
8 managers8 managers cut their position, the largest by value Ikarian Capital, LLC.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Ikarian Capital, LLC | 478,142 | $403,217 | -29% | 13F |
| BOOTHBAY FUND MANAGEMENT, LLC | 133,936 | $112,948 | -31% | 13F |
| Dauntless Investment Group, LLC | 80,574 | $67,948 | -81% | 13F |
| BlackRock, Inc. | 9,941 | $8,383 | 0% | 13F |
| UBS Group AG | 3,451 | $2,909 | -15% | 13F |
| MORGAN STANLEY | 468 | $395 | -87% | 13F |
| Cassaday & Co Wealth Management LLC | 6 | $6 | -45% | 13F |
| FMR LLC | 2 | $2 | -91% | 13F |
Unchanged
4 managers4 managers held the same number of shares, the largest by value ADAGE CAPITAL PARTNERS GP, L.L.C..
Questions and answers
- How many institutions hold Traws Pharma, Inc.?
- 34 managers reported Traws Pharma, Inc. on Form 13F for the quarter ended 30 June 2026, against 28 the quarter before.
- Who is the largest institutional holder of Traws Pharma, Inc.?
- ORBIMED ADVISORS LLC, with 1,203,260 shares worth $1 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Traws Pharma, Inc. in Q2 2026?
- 13 managers reported a new position and 7 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Traws Pharma, Inc., Q2 2026", https://app.tamarly.ai/holders/traws-pharma, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.